SlideShare a Scribd company logo
Dr. Ayesha Sherzada
FCPS trainee at THE INDUS HOSPITAL.
Karachi, Pakistan.
 Describe the types of ovarian cysts
 Clinical presentation
 Diagnosis
 Management
 Ovaries are normally not palpable in pre-menarche,
and after the menopause
 In the reproductive age group ovaries are palpable in
the lean pts.
 Ovarian size of different age groups
Premenopause 3.5 x 2 x 1.5 cm
Early menopause 1 – 2 yrs
2 x 1.5x0.5cm
Late menopause 2-5yrs
1.5x0.75x0.5cm
 Variation in diameter can result from:
 Endogenous hormonal production(varies with age and
menstrual cycle).
 Exogenous substances, including OCs, GnRH agonists
or ovulation-inducing medications, may affect size.
 Up to 10% of women will have some form of surgery
during their lifetime for the presence of an ovarian
mass.
 In premenopausal women almost all ovarian masses
and cysts are benign.
 The overall incidence of a symptomatic ovarian cyst in
a premenopausal female being malignant is
approximately 1:1000 increasing to 3:1000 at the age of
50.
green-top guidline #62, RCOG 2011
 Pain (acute / chronic).
 Mass
 An incidental finding
 Ascites
 Primary or secondary amenorrhea
 Menstrual irregularities
 Virilization
 Precocious puberty.
 Types of benign ovarian tumors varies with age.
 Functional—common in young girls, adolescents and
women in their reproductive years.
 Germ cell tumors—young women
 Benign epithelial tumors—older and post-menopausal
women.
 Abdominal and bimanual pelvic examination
may elicit a pelvic/ abdominal mass that may
be tender and will be separate from the uterus.
 In the acute presentation with pain the
diagnosis of accident to the ovarian cyst should
be considered (torsion, rupture, hemorrhage).
 Ultrasound scan.
 Pregnancy test, CRP, TLC.
 Tumour markers.
 CT and MRI can.
Tumour markers Ovarian tumour type Uses
Ca 125 Epithelial ovarian
cancers(serous),
borderline ovarian
tumours
Pre-operative, F/U
Ca 19-9 Epithelial ovarian
cancers(mucinous), BOT
Pre-operative, F/U
inhibin Granulosa cell tumours Follow up
B-HCG Dysgerminoma,
choriocarcinoma
Pre-operative, F/U
AFP Endodermal yolk sac,
immature teratoma
Pre-operative, F/U
LDH Dysgerminoma Pre-operative, F/U
 It is an effective way of triaging patients into low,
moderate, high risk for malignancy, according to
which the referral to a higher Centre and management
protocol will differ.
green-top guidline #62, RCOG 2011
Category Examples
Functional • Follicular cyst
• Corpus luteal cyst
• Theca luteal cyst
Inflammatory • Tubo-ovarian abscess
• endometrioma
Germ cell Benign teratoma
Epithelial • Serous cystadenoma
• Mucinous cystadenoma
• Brenner tumor
Sex cord stromal • Fibroma
• thecoma
- These are cysts related to ovarian function i.e. the
process of ovulation
- They are the most common detected cysts in the
reproductive age group
- Can be reach up to 10 cm in diameter
- Resolve spontaneously
 Cystic follicle is defined as follicular cyst of diameter
>3cm.
 Most common functional cysts.
 Rarely larger than 8cm.
 Lined by granulosa cells.
 Found incidentally on pelvic examination.
 Usually resolve within 4-8weeks with expectatant
management.
 May rupture or torse occasionally causing pain and
peritoneal symptoms.
 Less common than follicular cyst.
 May rupture leading to hemoperitoneum and
requiring surgical management (more in pt. taking
anti-coagulants or with bleeding disorder).
 Unruptured cysts may cause pain because of bleeding
into enclosed ovarian cyst cavity.
 Least common.
 Usually bilateral.
 Result from overstimulation of ovary by B-HCG.
 Do not commonly occur in normal pregnancy.
 Often associated with hydatidiform moles,
choriocarcinoma, multiple gestations, use of
clomiphene and GnRH analogues.
 May be quite large (up to 30cm), multicystic and
regress spontaneously.
 Most common site of involvement is the ovary.
 Endometriomas are pseudocysts formed by
invagination of the ovarian cortex, sealed off by
adhesions.
 They may completely replace normal ovarian tissue.
Cyst walls are usually thick and fibrotic.
 They may be unilocular or multilocular with thin or
thick septations.
 Management: medical and/or surgical.
 Serous cystadenoma (epithelial tumour)
 Mucinous cystadenoma (epithelial tumour)
 Dermoid cyst (germ cell tumour)
 Fibroma (sex cord stromal)
 Thecoma (sex cord stromal)
 Brenner’s tumor (epithelial tumour)
 Accounts for 20-30% of benign tumours in women
under 40.
 Bilateral- 10%.
 Risk of malignancy: 5-10% borderline malignant
20-25% malignant.
 GROSS: multilocular with papillary components.
 MICRO: low columnar epithelium with cilia.
 Characteristic psammoma bodies(end products of
degeneration of papillary implants) are found.
 Associated fibrosis may lead to “cystadenofibroma”.
 Have tendency to become huge masses.
 Round to ovoid masses with smooth capsules that are
usually translucent or bluish to whitish gray.
 Interior divide by discrete septa into loculi containing
clear, viscid fluid.
 Epithelium- tall, pale staining, secretory with basal
nuclei and goblet cells.
 5-10% are malignant.
 Most common ovarian tumor in youngs women (20-40yrs).
 The most common form of benign germ cell tumour is the
mature dermoid cyst(cystic teratoma).
 Often bilateral (10%).
 GROSS: hair, bone, cartilage, and a large amount of greasy
sebaceous material.
 MICRO: all the three germ layers (ectoderm, mesoderm,
endoderm).
 Malignant change occurs rare in <2% in women over 40yrs.
 Risk of torsion is 15%.
 An ovarian cystectomy is almost always possible, even if it
appears that only a small amount of ovarian tissue remains.
 Most common benign, solid, neoplasm of the ovary.
 Compose approx. 5% of benign ovarian neoplasm and
20% of all solid tumors of the ovary.
 Frequently seen in middle-aged women.
 Characterized by their firmness and resemblance to
myomas.
 Misdiagnosed as exophytic fibroids or primary ovarian
malignancy.
 Not hormonally active.
 Meig’s syndrome (ovarian fibromas, ascites and
hydrothorax) is uncommon and usually resolves after
surgical excision.
 Estrogen-secreting tumours.
 Often presents after menopause.
 Almost always confined to one ovary.
 Hormonally active and hence associated with
estrogenic or occasionally androgenic effects.
 Rarely malignant.
 Uncommon tumor grossly identical to fibroma.
 Small tumours.
 Found incidentally within ovary.
 On microscopy- markedly hyperplastic fibromatous
matrix interspersed with nests of epitheloid cells
showing coffee bean pattern.
 Considered uniformly benign. But scattered reports of
malignant Brenner’s available.
 Endocrinologically inert, but could be ass. with
virilization and endometrial hyperplasia.
 Torsion.
 Intracystic hemorrhage.
 Infection.
 Rupture.
 Pseudomyxoma peritonei.
 Malignancy.
green-top guidline #62, RCOG 2011
 Any solid ovarian lesion.
 Any ovarian lesion with papillary vegetation on the
cyst wall.
 Any adnexal mass >10cm in diameter.
 Palpable adnexal mass in a premenarchal or
postmenopausal women.
 Torsion or rupture suspected.
green-top guidline #62, RCOG 2011
 Diagnostic cytology has poor sensitivity to detect
malignancy, ranging from 25% to 82%.
 Not therapeutic, even when a benign mass is aspirated.
 Approx. 25% of cyst will recur within 1 year.
 Aspiration of a malignant mass induce spillage and
seeding of cancer cells into the peritoneal cavity.
green-top guidline #62, RCOG 2011
 Laparoscopy vs. laparotomy- decision based on
suspicion of malignancy and technical expertise.
 No RCTs comparing recurrence rate following
laparoscopy or laparotomy.
 The objective is to try cystectomy if possible.
 Laparoscopic surgery for benign ovarian tumor is
associated with less pain, shorter hospital stay, and
fewer adverse events than with laparotomy.
Cochrane database of systematic
reviews 2009
 Careful examination of the external surface of the
tumor and sampling of the peritoneal cavity.
 Avoidance of any tumoural rupture.
 Protection of the ovarian tumor with an endoscopic
bag before removal.
Benign ovarian masses

More Related Content

What's hot

Cervical and broad ligament fibroid
Cervical and broad ligament fibroidCervical and broad ligament fibroid
Cervical and broad ligament fibroid
Niranjan Chavan
 
Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]
hood ibanda
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
sailakshmidaayana
 
ENDOMETRIOSIS
ENDOMETRIOSISENDOMETRIOSIS
ENDOMETRIOSIS
NARENDRA C MALHOTRA
 
Germ cell tumors of ovary
Germ cell tumors of ovaryGerm cell tumors of ovary
Germ cell tumors of ovary
ashish223
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasia
azfarneyaz
 
Ovarian tumours
Ovarian tumoursOvarian tumours
Ovarian tumours
Salini Mandal
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
rezaul karim
 
Benign diseases of the ovary
Benign diseases of the ovaryBenign diseases of the ovary
Benign diseases of the ovaryMagda Helmi
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)student
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumors
Dr Anusha Rao P
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
SREEVIDYA UMMADISETTI
 
ENDOMETRIAL HYPERPLASIA PPT.pdf
ENDOMETRIAL HYPERPLASIA PPT.pdfENDOMETRIAL HYPERPLASIA PPT.pdf
ENDOMETRIAL HYPERPLASIA PPT.pdf
Bhavesh SOBHANI
 
Uterine leiomyoma (fibroid)
Uterine leiomyoma (fibroid)Uterine leiomyoma (fibroid)
Uterine leiomyoma (fibroid)
Sara Al-Ghanem
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcoma
Salini Mandal
 
ENDOMETRIAL CANCER
ENDOMETRIAL CANCERENDOMETRIAL CANCER
ENDOMETRIAL CANCER
Anu Manivannan
 
Pelvic mass panel discussion
Pelvic mass panel discussionPelvic mass panel discussion
Pelvic mass panel discussion
Niranjan Chavan
 
OVARIAN TUMOURS
OVARIAN TUMOURSOVARIAN TUMOURS
OVARIAN TUMOURS
Niranjan Chavan
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancy
Aboubakr Elnashar
 

What's hot (20)

Cervical and broad ligament fibroid
Cervical and broad ligament fibroidCervical and broad ligament fibroid
Cervical and broad ligament fibroid
 
Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Lect 3- overy cancer
Lect 3- overy cancerLect 3- overy cancer
Lect 3- overy cancer
 
ENDOMETRIOSIS
ENDOMETRIOSISENDOMETRIOSIS
ENDOMETRIOSIS
 
Germ cell tumors of ovary
Germ cell tumors of ovaryGerm cell tumors of ovary
Germ cell tumors of ovary
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasia
 
Ovarian tumours
Ovarian tumoursOvarian tumours
Ovarian tumours
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Benign diseases of the ovary
Benign diseases of the ovaryBenign diseases of the ovary
Benign diseases of the ovary
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)
 
Classification of ovarian tumors
Classification of ovarian tumorsClassification of ovarian tumors
Classification of ovarian tumors
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
ENDOMETRIAL HYPERPLASIA PPT.pdf
ENDOMETRIAL HYPERPLASIA PPT.pdfENDOMETRIAL HYPERPLASIA PPT.pdf
ENDOMETRIAL HYPERPLASIA PPT.pdf
 
Uterine leiomyoma (fibroid)
Uterine leiomyoma (fibroid)Uterine leiomyoma (fibroid)
Uterine leiomyoma (fibroid)
 
Uterine sarcoma
Uterine sarcomaUterine sarcoma
Uterine sarcoma
 
ENDOMETRIAL CANCER
ENDOMETRIAL CANCERENDOMETRIAL CANCER
ENDOMETRIAL CANCER
 
Pelvic mass panel discussion
Pelvic mass panel discussionPelvic mass panel discussion
Pelvic mass panel discussion
 
OVARIAN TUMOURS
OVARIAN TUMOURSOVARIAN TUMOURS
OVARIAN TUMOURS
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancy
 

Similar to Benign ovarian masses

benignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdfbenignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdf
samooo67890
 
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,JalandharBenign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Dr H.K. Cheema
 
Ovaries and Ovarian Tumours
Ovaries and Ovarian TumoursOvaries and Ovarian Tumours
Ovaries and Ovarian Tumours
Mujeeb M
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
VioletteRemedies
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
VioletteRemedies
 
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
College of Medicine, Sulaymaniyah
 
Ovaries
OvariesOvaries
Ovaries
Prasad CSBR
 
Benign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organsBenign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organsRuslan Migorianu
 
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationCa ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Dr.Bhavin Vadodariya
 
Benign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptxBenign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptx
AeyshaBegum
 
Ovarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareemOvarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareem
mahmoud kareem
 
Ovarian Tumors 2.pptx gynecology lecture
Ovarian Tumors 2.pptx gynecology lectureOvarian Tumors 2.pptx gynecology lecture
Ovarian Tumors 2.pptx gynecology lecture
Awais irshad
 
benignovariantumours-121018102005-phpapp02 (1).pptx
benignovariantumours-121018102005-phpapp02 (1).pptxbenignovariantumours-121018102005-phpapp02 (1).pptx
benignovariantumours-121018102005-phpapp02 (1).pptx
MustaphaOlolade
 
Diseases of ovary / OBS and GYN
Diseases of ovary / OBS and GYNDiseases of ovary / OBS and GYN
Diseases of ovary / OBS and GYN
Diaa Srahin
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
Shazia Iqbal
 
Ovarian cancer by oouth unit c medical students o&g
Ovarian cancer by oouth unit c medical students o&gOvarian cancer by oouth unit c medical students o&g
Ovarian cancer by oouth unit c medical students o&g
Tolulope Balogun
 
Carcinoma Endometrium
Carcinoma  EndometriumCarcinoma  Endometrium
Carcinoma Endometriumdrmcbansal
 
Fwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyFwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. Evoy
Jeku Jacob
 
Testicular tumor final
Testicular tumor finalTesticular tumor final
Testicular tumor final
Abdul Haleem
 

Similar to Benign ovarian masses (20)

benignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdfbenignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdf
 
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,JalandharBenign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
 
Ovaries and Ovarian Tumours
Ovaries and Ovarian TumoursOvaries and Ovarian Tumours
Ovaries and Ovarian Tumours
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
 
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
 
Ovaries
OvariesOvaries
Ovaries
 
Benign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organsBenign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organs
 
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationCa ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
 
Benign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptxBenign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptx
 
Ovarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareemOvarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareem
 
Ovarian Tumors 2.pptx gynecology lecture
Ovarian Tumors 2.pptx gynecology lectureOvarian Tumors 2.pptx gynecology lecture
Ovarian Tumors 2.pptx gynecology lecture
 
benignovariantumours-121018102005-phpapp02 (1).pptx
benignovariantumours-121018102005-phpapp02 (1).pptxbenignovariantumours-121018102005-phpapp02 (1).pptx
benignovariantumours-121018102005-phpapp02 (1).pptx
 
Diseases of ovary / OBS and GYN
Diseases of ovary / OBS and GYNDiseases of ovary / OBS and GYN
Diseases of ovary / OBS and GYN
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Ovarian cancer by oouth unit c medical students o&g
Ovarian cancer by oouth unit c medical students o&gOvarian cancer by oouth unit c medical students o&g
Ovarian cancer by oouth unit c medical students o&g
 
Carcinoma Endometrium
Carcinoma  EndometriumCarcinoma  Endometrium
Carcinoma Endometrium
 
Fwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. EvoyFwd: Benign Breast Disease Mr. Evoy
Fwd: Benign Breast Disease Mr. Evoy
 
Testicular tumor final
Testicular tumor finalTesticular tumor final
Testicular tumor final
 

Recently uploaded

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 

Recently uploaded (20)

Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 

Benign ovarian masses

  • 1. Dr. Ayesha Sherzada FCPS trainee at THE INDUS HOSPITAL. Karachi, Pakistan.
  • 2.  Describe the types of ovarian cysts  Clinical presentation  Diagnosis  Management
  • 3.  Ovaries are normally not palpable in pre-menarche, and after the menopause  In the reproductive age group ovaries are palpable in the lean pts.  Ovarian size of different age groups Premenopause 3.5 x 2 x 1.5 cm Early menopause 1 – 2 yrs 2 x 1.5x0.5cm Late menopause 2-5yrs 1.5x0.75x0.5cm
  • 4.  Variation in diameter can result from:  Endogenous hormonal production(varies with age and menstrual cycle).  Exogenous substances, including OCs, GnRH agonists or ovulation-inducing medications, may affect size.
  • 5.  Up to 10% of women will have some form of surgery during their lifetime for the presence of an ovarian mass.  In premenopausal women almost all ovarian masses and cysts are benign.  The overall incidence of a symptomatic ovarian cyst in a premenopausal female being malignant is approximately 1:1000 increasing to 3:1000 at the age of 50. green-top guidline #62, RCOG 2011
  • 6.  Pain (acute / chronic).  Mass  An incidental finding  Ascites  Primary or secondary amenorrhea  Menstrual irregularities  Virilization  Precocious puberty.
  • 7.  Types of benign ovarian tumors varies with age.  Functional—common in young girls, adolescents and women in their reproductive years.  Germ cell tumors—young women  Benign epithelial tumors—older and post-menopausal women.
  • 8.  Abdominal and bimanual pelvic examination may elicit a pelvic/ abdominal mass that may be tender and will be separate from the uterus.  In the acute presentation with pain the diagnosis of accident to the ovarian cyst should be considered (torsion, rupture, hemorrhage).
  • 9.  Ultrasound scan.  Pregnancy test, CRP, TLC.  Tumour markers.  CT and MRI can.
  • 10. Tumour markers Ovarian tumour type Uses Ca 125 Epithelial ovarian cancers(serous), borderline ovarian tumours Pre-operative, F/U Ca 19-9 Epithelial ovarian cancers(mucinous), BOT Pre-operative, F/U inhibin Granulosa cell tumours Follow up B-HCG Dysgerminoma, choriocarcinoma Pre-operative, F/U AFP Endodermal yolk sac, immature teratoma Pre-operative, F/U LDH Dysgerminoma Pre-operative, F/U
  • 11.  It is an effective way of triaging patients into low, moderate, high risk for malignancy, according to which the referral to a higher Centre and management protocol will differ. green-top guidline #62, RCOG 2011
  • 12.
  • 13.
  • 14.
  • 15. Category Examples Functional • Follicular cyst • Corpus luteal cyst • Theca luteal cyst Inflammatory • Tubo-ovarian abscess • endometrioma Germ cell Benign teratoma Epithelial • Serous cystadenoma • Mucinous cystadenoma • Brenner tumor Sex cord stromal • Fibroma • thecoma
  • 16. - These are cysts related to ovarian function i.e. the process of ovulation - They are the most common detected cysts in the reproductive age group - Can be reach up to 10 cm in diameter - Resolve spontaneously
  • 17.  Cystic follicle is defined as follicular cyst of diameter >3cm.  Most common functional cysts.  Rarely larger than 8cm.  Lined by granulosa cells.  Found incidentally on pelvic examination.  Usually resolve within 4-8weeks with expectatant management.  May rupture or torse occasionally causing pain and peritoneal symptoms.
  • 18.
  • 19.  Less common than follicular cyst.  May rupture leading to hemoperitoneum and requiring surgical management (more in pt. taking anti-coagulants or with bleeding disorder).  Unruptured cysts may cause pain because of bleeding into enclosed ovarian cyst cavity.
  • 20.
  • 21.  Least common.  Usually bilateral.  Result from overstimulation of ovary by B-HCG.  Do not commonly occur in normal pregnancy.  Often associated with hydatidiform moles, choriocarcinoma, multiple gestations, use of clomiphene and GnRH analogues.  May be quite large (up to 30cm), multicystic and regress spontaneously.
  • 22.
  • 23.
  • 24.
  • 25.  Most common site of involvement is the ovary.  Endometriomas are pseudocysts formed by invagination of the ovarian cortex, sealed off by adhesions.  They may completely replace normal ovarian tissue. Cyst walls are usually thick and fibrotic.  They may be unilocular or multilocular with thin or thick septations.  Management: medical and/or surgical.
  • 26.
  • 27.
  • 28.  Serous cystadenoma (epithelial tumour)  Mucinous cystadenoma (epithelial tumour)  Dermoid cyst (germ cell tumour)  Fibroma (sex cord stromal)  Thecoma (sex cord stromal)  Brenner’s tumor (epithelial tumour)
  • 29.  Accounts for 20-30% of benign tumours in women under 40.  Bilateral- 10%.  Risk of malignancy: 5-10% borderline malignant 20-25% malignant.  GROSS: multilocular with papillary components.  MICRO: low columnar epithelium with cilia.  Characteristic psammoma bodies(end products of degeneration of papillary implants) are found.  Associated fibrosis may lead to “cystadenofibroma”.
  • 30.
  • 31.  Have tendency to become huge masses.  Round to ovoid masses with smooth capsules that are usually translucent or bluish to whitish gray.  Interior divide by discrete septa into loculi containing clear, viscid fluid.  Epithelium- tall, pale staining, secretory with basal nuclei and goblet cells.  5-10% are malignant.
  • 32.
  • 33.  Most common ovarian tumor in youngs women (20-40yrs).  The most common form of benign germ cell tumour is the mature dermoid cyst(cystic teratoma).  Often bilateral (10%).  GROSS: hair, bone, cartilage, and a large amount of greasy sebaceous material.  MICRO: all the three germ layers (ectoderm, mesoderm, endoderm).  Malignant change occurs rare in <2% in women over 40yrs.  Risk of torsion is 15%.  An ovarian cystectomy is almost always possible, even if it appears that only a small amount of ovarian tissue remains.
  • 34.
  • 35.  Most common benign, solid, neoplasm of the ovary.  Compose approx. 5% of benign ovarian neoplasm and 20% of all solid tumors of the ovary.  Frequently seen in middle-aged women.  Characterized by their firmness and resemblance to myomas.
  • 36.  Misdiagnosed as exophytic fibroids or primary ovarian malignancy.  Not hormonally active.  Meig’s syndrome (ovarian fibromas, ascites and hydrothorax) is uncommon and usually resolves after surgical excision.
  • 37.
  • 38.  Estrogen-secreting tumours.  Often presents after menopause.  Almost always confined to one ovary.  Hormonally active and hence associated with estrogenic or occasionally androgenic effects.  Rarely malignant.
  • 39.  Uncommon tumor grossly identical to fibroma.  Small tumours.  Found incidentally within ovary.  On microscopy- markedly hyperplastic fibromatous matrix interspersed with nests of epitheloid cells showing coffee bean pattern.  Considered uniformly benign. But scattered reports of malignant Brenner’s available.  Endocrinologically inert, but could be ass. with virilization and endometrial hyperplasia.
  • 40.
  • 41.  Torsion.  Intracystic hemorrhage.  Infection.  Rupture.  Pseudomyxoma peritonei.  Malignancy.
  • 42.
  • 44.
  • 45.  Any solid ovarian lesion.  Any ovarian lesion with papillary vegetation on the cyst wall.  Any adnexal mass >10cm in diameter.  Palpable adnexal mass in a premenarchal or postmenopausal women.  Torsion or rupture suspected. green-top guidline #62, RCOG 2011
  • 46.  Diagnostic cytology has poor sensitivity to detect malignancy, ranging from 25% to 82%.  Not therapeutic, even when a benign mass is aspirated.  Approx. 25% of cyst will recur within 1 year.  Aspiration of a malignant mass induce spillage and seeding of cancer cells into the peritoneal cavity. green-top guidline #62, RCOG 2011
  • 47.  Laparoscopy vs. laparotomy- decision based on suspicion of malignancy and technical expertise.  No RCTs comparing recurrence rate following laparoscopy or laparotomy.  The objective is to try cystectomy if possible.  Laparoscopic surgery for benign ovarian tumor is associated with less pain, shorter hospital stay, and fewer adverse events than with laparotomy. Cochrane database of systematic reviews 2009
  • 48.  Careful examination of the external surface of the tumor and sampling of the peritoneal cavity.  Avoidance of any tumoural rupture.  Protection of the ovarian tumor with an endoscopic bag before removal.

Editor's Notes

  1. Asymptomatic – accidentally discovered on USG. Chromic pattern of pain, increasing abdominal girth over week or months. Associated with secondary symptoms of anorexia, nausea, vomiting, urinary frequency. Could be associated with primary or secondary amenorrhea, menstrual irregularities, virilization, precocious puberty. Become acutely symptomatic if undergoes torsion, rupture or hemorrhage. Benign ovarian neoplasm are indistinguishable clinically from malignant counterparts.
  2. GPE. CHEST for hydrothorax as in meig’s syndrome. Virilization?? Ascites, abd distention.
  3. A pelvic ultrasound is the single most effective way of evaluating an ovarian mass with transvaginal ultrasonography being preferable due to its increased sensitivity over trans abdominal ultrasound. At the present time the routine use of computed tomography and MRI for assessment of ovarian masses does not improve the sensitivity or specificity obtained by transvaginal ultrasonography in the detection of ovarian malignancy. A serum CA-125 assay does not need to be undertaken in all premenopausal women when an ultrasonography diagnosis of a simple ovarian cyst has been made. Lactate dehydrogenase (LDH), α-FP and hCG should be measured in all women under age 40 with a complex ovarian mass because of the possibility of germ cell tumors. An estimation of the risk of malignancy is essential in the assessment of an ovarian mass. A systematic review of diagnostic studies concluded that the RMI I is the most effective for women with suspected ovarian cancer. CA-125 is unreliable in differentiating benign from malignant ovarian masses in premenopausal women because of the increased rate of false positives and reduced specificity. This is as a result of CA-125 being raised in numerous conditions including fibroids, endometriosis, adenomyosis and pelvic infection. It is also important to note that CA-125 is primarily a marker for epithelial ovarian carcinoma and is only raised in 50% of early stage disease. ● A serum CA-125 assay is not necessary when a clear ultrasonographic diagnosis of a simple ovarian cyst has been made.23–26 ● If a serum CA-125 assay is raised and less than 200 units/ml, further investigation may be appropriate to exclude/treat the common differential diagnoses (see Table 1). ● When serum CA-125 levels are raised, serial monitoring of CA-125 may be helpful as rapidly rising levels are more likely to be associated with malignancy than high levels which remain static. ● If serum CA-125 assay more than 200 units/ml, discussion with a gynaecological oncologist is recommended.
  4. Granulosa cell tumours (type of sex cord stromal tumour) Dysgerminoma, choriocarcinoma (germ cell tumour) Endodermal yolk sac, immature teratoma(germ cell tumours)
  5. It was first describes by Jacob in 1990, since then evolved into RMI 1,2,3.,4.RMI 1 is simple and reproducible to use, but its utility is negatively affected in the premenopausal women, primarily bcz of the incidence of endometrioma, borderline tumors, non-epithelial tumors which inc. level of CA125.
  6. A recent systematic review36 showed the pooled sensitivities and specificities of an RMI I score of 200 in the detection of ovarian malignancies to be: RMI I sensitivity 78% (95% CI 71-85%), specificity 87% (95% CI 83-91%).
  7. There are simple ultrasound rules derived from the IOTA Group. The use of specific ultrasound morphological findings without CA-125 has been shown to have high sensitivity, specificity and likelihood ratios. If not clearly classifiable from these rules, further investigation by a specialist in gynaecological ultrasound is appropriate. Women with an ovarian mass with any of the M-rules ultrasound findings should be referred to a gynaecological oncological service. The American College of Obstetricians and Gynecologists and the Society of Obstetricians and Gynaecologists of Canada have guidelines for the management of premenopausal women with a pelvic mass.3,4They consider the following features suspicious for ovarian malignancy and their presence would warrant referral to a gynaecological oncologist: serum CA-125 of more than 200 units/ml; ascites; evidence of abdominal or distant metastasis; a first-degree relative with breast or ovarian cancer. In the largest study validating these guidelines 30% of premenopausal women with ovarian cancer would not have been regarded as high risk.
  8. Rx is expectant, with analgesia. Occasionally, surgery may be necessary if there has been significant bleeding to wash out the pelvis and perform ovarian cystectomy.
  9. Often presents after menopause with manifestations of excess estrogen production, usually postmenopausal bleeding.although benign, they may induce endometrial carcinoma. Solid fibromatous lesions that show varying degree of yellow or orange discoloration. TYPES: Luteinized thecoma – younger, sclerosing peritonitis and ascites. Leydeig cell thecoma – ass. with Reinke crystals.
  10. Arise from Walthard cell rests, also from surface epithelium, rete ovarii and ovarian stroma. They contain urothelial epithelium. May rarely secrete estrogen.
  11. Women with small (less than 50 mm diameter) simple ovarian cysts generally do not require follow-up as these cysts are very likely to be physiological and almost always resolve within 3 menstrual cycles. Women with simple ovarian cysts of 50–70 mm in diameter should have yearly ultrasound follow-up. Those with larger simple cysts should be considered for either further imaging (MRI) or surgical intervention. Combined oral contraceptives appear to be of no benefits.